-
The FDA has approved a potassium channel blocker to improve walking in adults with multiple sclerosis.
-
Even if asymptomatic, early elective aortic valve replacement should be considered for increasingly symptomatic patients with severe aortic valve stenosis because they have a poor prognosis with a high event rate and a risk of rapid functional deterioration, especially if the peak aortic jet velocity is above 5.5 m/sec.
-
The burgeoning population of individuals with type 2 diabetes corresponds to a parallel increase in obesity.
-
The ECG shown above was obtained from a 66-year-old woman with chest discomfort. What is going on in this tracing?
-
Guidelines to assess cardiovascular risk are often inconsistent and poorly developed.
-
About a third of patients with sleep apnea have chronic cough. Such patients are more likely to be women and to have heartburn and rhinitis.
-
A second human glucagon-like peptide 1 (glp-1) analog/receptor agonist has been approved by the FDA for the treatment of type 2 diabetes mellitus (DM2).
-
Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions
-
This engaging epidemiologic survey assessed microbial contamination of soda-fountain drinks, dispensed from nine different fountain machines, relative to current U.S. drinking water standards.
-
Resting QRS duration is an independent predictor of cardiac death and/or myocardial infarction in patients with suspected CAD.
